why doctor prescribe antibiotics for viral infection instead
of antiviral drugs?
Answer Posted / madugula swathi
the antibiotics are inhibits the bacteria r viruses growth..and inhibits to the their synthesis..
| Is This Answer Correct ? | 0 Yes | 2 No |
Post New Answer View All Answers
if calibration of 12 bowl dissolution apparatus does not meet a single stage procedure how you can proceed calibration
what is the defination of Change Control given in various guidelines?
Hi, I am studying Bpharmacy final year. 1)I want to interview questions for facing basic interview.please help me to provide model papers for all pharma companies and give ur valuable suggestions also. 2)Send me important links for BPharmacy interviews. 3)How should i prepare for facing interview,please give me suggestion. My email id:1010.murthy@gmail.com
why dissolution multimedia profile of drug is important. what are the specifications for tablets ,capsules,powders etc
What should be the minimum limit of a working standard?
Discuss the potential side effects and risks associated with Alprazolam usage. How would you manage or mitigate these side effects in a patient?
i am preparing for Drug inspector exam.If u have previous questions please send me.
What exepients are used in dry powder injections?
How would you make a physician to prescribe your medicine rather than that of the competitor?
if one drug is acidic in nature and the other drug is basic in nature, e.g. desloratadine is soluble in acidic environment i.e 0.1N HCL whereas Montelukast Sodium is soluble in basic environment i.e. .2% SLS. How can we choose a common media for there Dissolution?
What is your work experience in pharmaceutical field?
How do you balance the benefits and risks of Alprazolam treatment when considering its prescription for an elderly patient with multiple comorbidities?
What are the common indications for prescribing Alprazolam? How does it differ from other medications used to treat anxiety?
how impurity is analyzed in a tablet
How to conduct Literature Survey for Generics Development for European Market